Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

NCT05919329 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Castration Resistant Prostate Cancer
Castration Sensitive Prostate Cancer
Prostate Adenocarcinoma

Interventions

DRUG: Piflufolastat
PROCEDURE: PSMA PET/CT Scan
PROCEDURE: PSMA PET/MRI scan
PROCEDURE: Biospecimen Collection
OTHER: Electronic Health Record Review

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]